44 -1 (63) 2024 — Akhmedov F.K.,Yakubova S.N. — HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR FETAL LOSS

HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR FETAL LOSS

Akhmedov F.K., Andijon davlat tibbiyot instituti O’zbekiston, Bukhara State Medical Institute Bukhara State Medical Institute named after Abu Ali ibn Sina

Yakubova S.N., Andijon davlat tibbiyot instituti O’zbekiston, Bukhara State Medical Institute Bukhara State Medical Institute named after Abu Ali ibn Sina

Negmatshoeva Kh.N., Andijon davlat tibbiyot instituti O’zbekiston, Bukhara State Medical Institute Bukhara State Medical Institute named after Abu Ali ibn Sina

Akhmadzhonova G.M. Andijon davlat tibbiyot instituti O’zbekiston, Bukhara State Medical Institute Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The constant increase in fetal loss in the early gestational period remains an urgent problem of obstetric practice. Reaching a loss rate of up to 25-40% during implantation, spontaneous abortion is the result of registered pregnancies in more than 14%, and the frequency of short-term fetal losses among women who have confirmed pregnancy for the first time reaches more than 10%. Very early pregnancy losses during implantation and early pregnancy retention, just before placentation, occur mainly due to unspecified causes and insufficient knowledge about the causes of fetal loss.

Keywords: spontaneous abortion, homocysteine, fetal loss, obstetric complications

First page

243

Last page

246

For citation: Akhmedov F.K.,Yakubova S.N.,Negmatshoeva Kh.N., Akhmadzhonova G.M. – HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR FETAL LOSS //Ne wDay in Medicine 2024 1(63): 243–246 https://newdaymedicine.com/index.php/2024/01/21/l-772/

LIST OF REFERENCES:

  1. Akhmedov F. K., Negmatullaeva M. N., Kurbanova Z. S. Modern views on the problem of preeclampsia // New day in medicine. 2018; 1(21):180-185.
  2. Akhmedov F. K., Negmatullaeva M. N. Features of the state of central hemodynamics and hemostasis in pregnant women with preeclampsia of varying degrees and severity // New Day of Medicine. 2020; 1(29)29-33.
  3. Akhmedov F.K., Negmatullaeva M.N., Avakov V.E. Features of renal blood flow and dynamics of uric acid concentration in women with pregnancy complicated by preeclampsia // Clinical nephrology. 2018; 1:38-40.
  4. Jean-Christophe Gris, Thomas V. Perneger, Isabelle Que´re´, Eric Mercier, Pascale Fabbro-Peray, Ge´raldine Lavigne-Lissalde, Me´de´ric Hoffet, Herve´ De´chaud, Jean-Christophe Boyer, Sylvie Ripart-Neveu, Marie-Laure Tailland, Jean-Pierre Daure`s, Pierre Mare`s, and Michel Dauzat // Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study / BLOOD, 15 November 2003; 102(10):3504-3513.
  5. Obstetrics: A National Guide. Brief edition / Ed. E.K. Ailamazyan, V.N. Serova, V.E. Radzinsky, G.M. Savelyeva. – M.: GEOTAR-Media, 2015;608.
  6. Diamond JR, Wu B, Agarwal N, et al. Pharmacokinetic drug–drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors. // Invest New Drugs . 2015; 33:691-699.
  7. Gulnoza Akhmadjonova, Gulnoza Turayeva. Evaluation of the microbial flora of the genital tract and the morphofunctional state of the endometrium in antiphospholipid syndrome // American Journal of Medicine and Medical Sciences 2022, 12(5):579-583 DOI: 10.5923/j.ajmms.20221205.26 579-583.
  8. Gulnoza Akhmadjonova, Shukhrat Teshaev, Dilbar Nazhmutdinova, Khabiba Negmatshaeva. Clinical Characteristics of Women with Early Gestational Fetal Loss with Antiphospholipid Syndrome // American Journal of Medicine and Medical Sciences 2021, 11(8):563-568. DOI: 10.5923/j.ajmms.20211108.03.
  9. Maniyozova GM, Turaeva G. Yu., Babich SM, Negmatshaeva HN, Mamajanova SA, Abdukaharova S. , Hakimova K. Use of Essentiale Forte N in Complex Treatment of Antiphospholipid Syndrome in Women of Ferghana Valley // Journal of Medical Research and Development . – Germany, Jan. 2015; 4(1):8-10.
  10. Maniyozova G., Negmatshaeva H., Yuldasheva O., Turaeva G., Parpieva D. Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state // European medical Heals and Pharmaceutical Journal. – Chechiya , 2014; 7(I2):1-2.
  11. Mori M, Bogdan A, Balassa T, Csabai T, Szekeres-Bartho J. The decidua-the maternal bed embracing the embryo-maintains the pregnancy. // Semin Immunopathol. 2016; 38:635-649.
  12. Sharma S, Godbole G, Modi D. Decidual control of trophoblast invasion. // Am J Reprod Immunol. 2016; 75:341-350.
  13. Teshaev Sh. Zh., Akhmadjonova G. M. Endometry as a source of nutrients, growth factors in antiphospholipid syndrome, morphological features of gravidary endometry // Tibbiyotda yangi kun 2021; 3(35):32-37.
  14. Vinketova K, Mourdjeva M, Oreshkova T. Human decidual stromal cells as a component of the implantation niche and a modulator of maternal immunity. // J Pregnancy. 2016; 2016:868-943.

file

download